Prevention and Reduction of AD‐type Pathology in PDAPP Mice Immunized with Aβ1–42
暂无分享,去创建一个
K. Johnson-wood | P. Seubert | D. Schenk | H. Grajeda | K. Khan | F. Soriano | N. Vasquez | T. Yednock | D. Games | N. Wehner | T. Guido | F. Bard
[1] J. Kaye,et al. High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. , 1998, Archives of neurology.
[2] S. Paul,et al. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition , 1997, Nature Genetics.
[3] David Bruce Lewis,et al. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation , 1996, Neurology.
[4] G. Schellenberg,et al. Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease , 1996, Nature Medicine.
[5] L. Mucke,et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.
[6] B. Hyman,et al. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions , 1993, Neuron.
[7] M. Pericak-Vance,et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[8] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[9] D. Selkoe. Cell biology of the beta-amyloid precursor protein and the genetics of Alzheimer's disease. , 1996, Cold Spring Harbor symposia on quantitative biology.